Literature DB >> 25483664

Infants and the seasonal influenza vaccine. A global perspective on safety, effectiveness, and alternate forms of protection.

Leah F Moriarty1, Saad B Omer.   

Abstract

Seasonal influenza is a substantial cause of severe illness among infants under 6 months of age globally. There are multiple methods of vaccination against influenza, including inactivated and live vaccines that are approved and recommended for children and adults over 6 months of age, but there is no vaccine that protects against seasonal influenza for children <6 months of age. This group is at a high risk of severe illness and is associated with higher rates of hospitalization and mortality during the influenza season. In absence of an available vaccine, approaches protecting young infants from influenza must be taken seriously. These methods include vaccinating pregnant women for influenza as a method of protecting mothers and the fetus as well as vaccinating caregivers and close contacts of individuals in this age group.

Entities:  

Keywords:  cocooning; maternal antibodies; maternal immunization; seasonal influenza; young infants

Mesh:

Substances:

Year:  2014        PMID: 25483664      PMCID: PMC5283389          DOI: 10.4161/hv.29669

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  39 in total

Review 1.  Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis.

Authors:  Harish Nair; W Abdullah Brooks; Mark Katz; Anna Roca; James A Berkley; Shabir A Madhi; James Mark Simmerman; Aubree Gordon; Masatoki Sato; Stephen Howie; Anand Krishnan; Maurice Ope; Kim A Lindblade; Phyllis Carosone-Link; Marilla Lucero; Walter Ochieng; Laurie Kamimoto; Erica Dueger; Niranjan Bhat; Sirenda Vong; Evropi Theodoratou; Malinee Chittaganpitch; Osaretin Chimah; Angel Balmaseda; Philippe Buchy; Eva Harris; Valerie Evans; Masahiko Katayose; Bharti Gaur; Cristina O'Callaghan-Gordo; Doli Goswami; Wences Arvelo; Marietjie Venter; Thomas Briese; Rafal Tokarz; Marc-Alain Widdowson; Anthony W Mounts; Robert F Breiman; Daniel R Feikin; Keith P Klugman; Sonja J Olsen; Bradford D Gessner; Peter F Wright; Igor Rudan; Shobha Broor; Eric A F Simões; Harry Campbell
Journal:  Lancet       Date:  2011-11-10       Impact factor: 79.321

2.  Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.

Authors:  Isabel Leroux-Roels; Eva Vets; Ralf Freese; Michael Seiberling; Françoise Weber; Camille Salamand; Geert Leroux-Roels
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

Review 3.  Delivering influenza vaccine to pregnant women.

Authors:  Allison L Naleway; Wendy J Smith; John P Mullooly
Journal:  Epidemiol Rev       Date:  2006-05-26       Impact factor: 6.222

4.  Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response.

Authors:  W C Gruber; P M Darden; J G Still; J Lohr; G Reed; P F Wright
Journal:  Vaccine       Date:  1997 Aug-Sep       Impact factor: 3.641

5.  Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

Authors:  R Bodewes; G de Mutsert; F R M van der Klis; M Ventresca; S Wilks; D J Smith; M Koopmans; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Vaccine Immunol       Date:  2011-01-05

Review 6.  Adjuvanted influenza vaccines.

Authors:  Orli Even-Or; Sarit Samira; Ronald Ellis; Eli Kedar; Yechezkel Barenholz
Journal:  Expert Rev Vaccines       Date:  2013-09       Impact factor: 5.217

7.  Influenza-associated deaths among children in the United States, 2003-2004.

Authors:  Niranjan Bhat; Jennifer G Wright; Karen R Broder; Erin L Murray; Michael E Greenberg; Maleeka J Glover; Anna M Likos; Drew L Posey; Alexander Klimov; Stephen E Lindstrom; Amanda Balish; Marie-jo Medina; Teresa R Wallis; Jeannette Guarner; Christopher D Paddock; Wun-Ju Shieh; Sherif R Zaki; James J Sejvar; David K Shay; Scott A Harper; Nancy J Cox; Keiji Fukuda; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

8.  Oil-in-water emulsion adjuvant with influenza vaccine in young children.

Authors:  Timo Vesikari; Markus Knuf; Peter Wutzler; Aino Karvonen; Dorothee Kieninger-Baum; Heinz-Josef Schmitt; Frank Baehner; Astrid Borkowski; Theodore F Tsai; Ralf Clemens
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

9.  Recommendations for prevention and control of influenza in children, 2011-2012.

Authors: 
Journal:  Pediatrics       Date:  2011-09-02       Impact factor: 7.124

10.  Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age.

Authors:  R A Karron; M C Steinhoff; E K Subbarao; M H Wilson; K Macleod; M L Clements; L F Fries; B R Murphy
Journal:  Pediatr Infect Dis J       Date:  1995-01       Impact factor: 2.129

View more
  4 in total

1.  Does Choice of Influenza Vaccine Type Change Disease Burden and Cost-Effectiveness in the United States? An Agent-Based Modeling Study.

Authors:  Jay V DePasse; Kenneth J Smith; Jonathan M Raviotta; Eunha Shim; Mary Patricia Nowalk; Richard K Zimmerman; Shawn T Brown
Journal:  Am J Epidemiol       Date:  2017-05-01       Impact factor: 4.897

2.  Influenza hospitalizations in Australian children 2010-2019: The impact of medical comorbidities on outcomes, vaccine coverage, and effectiveness.

Authors:  Daniel A Norman; Allen C Cheng; Kristine K Macartney; Hannah C Moore; Margie Danchin; Holly Seale; Jocelynne McRae; Julia E Clark; Helen S Marshall; Jim Buttery; Joshua R Francis; Nigel W Crawford; Christopher C Blyth
Journal:  Influenza Other Respir Viruses       Date:  2021-11-16       Impact factor: 4.380

Review 3.  Immunization of preterm infants: current evidence and future strategies to individualized approaches.

Authors:  Mats Ingmar Fortmann; Johannes Dirks; Sybelle Goedicke-Fritz; Johannes Liese; Michael Zemlin; Henner Morbach; Christoph Härtel
Journal:  Semin Immunopathol       Date:  2022-08-03       Impact factor: 11.759

4.  COVID-19 and rationally layered social distancing.

Authors:  Richard A Stein
Journal:  Int J Clin Pract       Date:  2020-04-06       Impact factor: 3.149

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.